Database of Pediatric Patients with Cirrhosis of the Liver
Study on the Efficacy of an Investigational Medication for Hypertension
Not Recruiting
18 years or below
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Cirrhosis
Age:
18 years or below
Gender: All
Who can participate: Adults aged 18 to 65 with a diagnosis of hypertension may be eligible. Participants should not have a history of cardiovascular disease or be currently on antihypertensive medication.
Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. They will take the assigned treatment daily for 12 weeks. The placebo will be an inactive substance designed to mimic the investigational medication without therapeutic effects.
Updated on
19 Feb 2024.
Study ID: 1011003831 (0809-23)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
